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Summary
The IB kinase (IKK) activity is critical for processing
IB inhibitory proteins and activating the NF-B sig-
naling, which is involved in a series of physiological
and developmental steps in vertebrates [1–4]. The
IKK activity resides in two catalytic subunits, IKK1
and IKK2, and two regulatory subunits, NEMO and
ELKS [5–8]. IKK2 is the major cytokine-responsive
IB kinase [9–11] because depletion of IKK1 does not
interfere with the IKK activity [12–14]. In fact, IKK1−/−
mice display morphological abnormalities that are in-
dependent of its kinase activity and NF-B activation
[12–14]. Hence, using zebrafish (Danio rerio) as a
model, we examined the evolutionary role of IKK1 in
modulating NF-B. Ikk1−/− zebrafish embryos present
head and tail malformations and, surprisingly, show
upregulation of NF-B-responsive genes and increased
NF-B-dependent apoptosis. Overexpression of ikk1
leads to midline structure defects that resemble NF-
B blockage in vivo [1]. Zebrafish Ikk1 forms com-
plexes with NEMO that represses NF-B in vertebrate
cells. Indeed, truncation of its NEMO binding domain
(NBD) restores NF-B-dependent transcriptional ac-
tivity and, consequently, the ikk1-overexpressing phe-
notype. Here, we report that Ikk1 negatively regulates
NF-B by sequestering NEMO from active IKK com-
plexes, indicating that IKK1 can function as a repres-
sor of NF-B.
Results and Discussion
The zebrafish ikk1 gene (GenBank AY735397) encodes
a 758 aa polypeptide that, like all IKK1 homologs, com-
prises an N-terminal serine-threonine kinase catalytic
domain (KD), a leucine-zipper-like amphipathic α-helix
(LZ), and a C-terminal helix-loop-helix domain (HLH)
(Figure 1A). The zebrafish ikk1 gene spans about 13
kilobases (kb) and, despite the intronic expansion on
the human ortholog (40 kb total), both genes are com-
posed of 21 exons (data not shown). The ikk1 locus is
located between 40 and 43 cM in linkage group (LG)
13 and is syntenic to a specific region of the human
chromosome containing IKK1 (Chr. 10) (Figure 1B).
Northern-blot analysis indicates that ikk1 is expressed
at higher levels during early embryonic stages (Figure
1C), implying a maternal origin for the ikk1 transcripts.
Whole-mount in situ hybridization assays show that
ikk1 is abundantly expressed from the blastula period*Correspondence: verma@salk.edu
1These authors contributed equally to this work.through early gastrulation (Figure 1D). During early
somitogenesis, ikk1 transcripts are dorsally localized at
the level of the segmental plate and the presumptive
notochord. At the 18-somite stage, ikk1 expression be-
comes largely detectable throughout the somitic tissue
(Figure 1D). At late embryonic stages, ikk1 expression
is particularly evident in the tectum, cerebellum, hind-
brain region, and eyes. After hatching, ikk1 transcripts
can also be detected in the myotomes and pectoral fins
(Figure 1D).
To delineate the role of Ikk1 in vivo, we first knocked
down its expression by using morpholinos (ikk1-MO).
After injecting 1.5 ng ikk1-MO into one-cell-stage em-
bryos (n = 497), 30% of the injected embryos (ikk1 mor-
phants) showed a “strong” phenotype, including small
and rounded head, small eyes, decreased pigmenta-
tion, and a shortened tail by 42 hr postfertilization (hpf)
(Figure 1E). Sixty-eight percent of the ikk1 morphants
showed milder abnormalities along the head and tail
(“weak” phenotype, Figure 1E). Phenotypic changes
were rarely observed after injecting a 4-mispair MO
control, ikk1m4-MO (3%, n = 426). In vitro translation
assays were performed to validate our approach (Fig-
ure 1E). In situ hybridization assays indicated that the
somites (marked by myoD) were fused in ikk1 mor-
phants (Figure 1F). Furthermore, the central nervous
system (CNS), including midbrain, hindbrain, and mid-
brain/hindbrain (M/H) boundary (marked by sp8),
showed alterations when compared to the control em-
bryos (Figure 1F).
To analyze the expression of NF-κB-inducible genes
in Ikk1−/− embryos, we isolated total RNA from nonin-
jected embryos or morphants (ikk1-MO and ikk1m4-
MO) by 42 hpf and performed real-time polymerase
chain reaction (real-time PCR). Unexpectedly, all of the
selected NF-κB targets, including ikbaa, NF-kB2/p100,
interleukin-1β (IL-1b), and interferon (IFN), were upregu-
lated in ikk1 morphants (Figure 2A). The level of fgf-8
expression also increased, confirming a previous ob-
servation in IKK1−/− mice [15]. No differences on the
expression levels of nontarget genes, such as p65 and
trail, were observed (Figure 2A). At earlier stages (24
hpf), we also detected upregulation of some target
genes, such as IFN and TNFa, in ikk1 morphants (data
not shown). Because NF-κB traditionally induces pro-
apoptotic and antiapoptotic genes in diverse cell types
[16], we used a TUNEL assay to examine how ikk1
knockdown would affect apoptosis. TUNEL-positive
cells were found in the whole body, including tail epi-
thelia and mesenchyme, of ikk1 morphants, indicating
that the truncated tail in ikk1 morphants might be a
consequence of enhanced apoptosis (Figure 2B). To
confirm whether the increased apoptosis observed in
ikk1 morphants was dependent on constitutive NF-κB
activation, we treated these embryos at 10 hpf (bud
stage) with NF-κB-activation inhibitor (NAI) [17]. At 26
hpf, we observed that NAI treatment mostly rescued
apoptosis in ikk1 morphants (Figure 2C), confirming
that the increased apoptosis was due to NF-κB hyper-
activity. We believe that in ikk1 morphants, NF-κB might
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1292Figure 1. Characterization of Zebrafish Ikk1
(A) Domain structure and its level of identity
(and similarity) to mammalian IKK1 proteins.
The following abbreviations are used: KD, ki-
nase domain; LZ, leucine zipper; and HLH,
helix-loop-helix.
(B) Mapping of the ikk1 locus. Approximate
position along the linkage group (LG) is indi-
cated in centimorgans (cM). Syntenic genes
across zebrafish and human chromosomes
are shown.
(C) Temporal expression during embyogen-
esis. Total RNA isolated from staged em-
bryos was analyzed by Northern blot, with
probes for ikk1 and ef1a (integrity control).
Visualization of 28S rRNA was performed as
loading control.
(D) Spatial ikk1 expression by in situ hybridiza-
tion analysis. Developmental stages are indi-
cated with embryos in lateral or dorsal view. A
sense probe was used as a negative control.
The following abbreviations are used: cb, cer-
ebellum; hb, hindbrain; mt, myotomes; nt, no-
tochord; pf, pectoral fin; sm, somites; sp, seg-
mental plate; tt, tectum; and vz, ventricular
zone.
(E) Representative image of embryos (42 hpf)
injected with ikk1 morpholino (ikk1-MO) or
4-mispair control (ikk1m4-MO). The “strong”
(top) and “weak” (middle) phenotypes are
shown. Morpholino activity was validated by
in vitro translation assay (bottom panel).
(F) Whole-mount in situ hybridization of mor-
phants (32 hpf, lateral view), with probes for
somites (myoD) and midbrain/hindbrain (M/H)
boundary (sp8). The following abbreviations
are used: mb, midbrain; hb, hindbrain; and
m/h, M/H boundary.have a proapoptotic role because induction of some (
zproinflammatory cytokines, such as IL-1b and IFN,
could synergize cell death [16]. A proapoptotic role for i
NF-κB has also been suggested in avians, where high
levels of the NF-κB protein c-Rel are observed in em- t
cbryonic cells undergoing programmed cell death during
chick development [18, 19]. s
fTo investigate the role of Ikk1 as a putative repressor
of NF-κB, we examined the expression level of some s
eNF-κB-responsive genes in IKK1−/− mouse embryonic
fibroblasts (MEFs) constitutively expressing EGFP (nega- i
mtive control), murine IKK1 (mIKK1), or zebrafish ikk1.
The transcription of all NF-κB target genes tested, in- e
acluding interleukin-6 (IL-6) and IkBa, inducible nitric ox-
ide synthase (iNOS), and macrophage inflammatory e
pprotein (MIP)-1α, were dramatically downregulated in
TNFα-treated cells expressing zebrafish ikk1 when (
bcompared to the controls (Figure 3A and data not shown).
Electrophoretic mobility-shift assays (EMSA) with total i
textracts from transfected 293T cells confirmed that
TNFα-induced NF-κB DNA binding was severely re- b
duced in the presence of increasing amounts of zebra-
fish Ikk1 when compared to the mIKK1 (Figure 3B). To d
Nverify whether this repression also operates at the tran-
scriptional level in zebrafish, we performed NF-κB- z
edependent luciferase assays with zebrafish (ZF4) cells.
In contrast to mIKK1, overexpression of ikk1 inhibited h
cNF-κB-mediated transcriptional activity in ZF4 cells af-
ter induction with bacterial lipopolysaccharides (LPS) tFigure 3C). Taken together, these results point out that
ebrafish Ikk1, unlike mIKK1, prevents NF-κB activation
n vertebrate cells.
By using a dominant-negative form of IκBα (IκBαM)
hat irreversibly blocks NF-κB signaling, we have re-
ently shown that inhibition of NF-κB activity leads to
evere midline defects (no tail-like phenotype) in zebra-
ish embryos [1] (see also Figure 4E). Thus, we rea-
oned that, if ikk1 negatively regulates NF-κB, its over-
xpression might lead to the same phenotype observed
n IκBαM-overexpressing embryos. To test this, we
icroinjected ikk1 cRNA into one-cell-stage zebrafish
mbryos. Severe midline defects including short A/P
xis and small eyes (in severe cases, cyclopia) were
vident (Figure 3D). As observed in IκBαM-overex-
ressing embryos, we also noticed interrupted no tail
ntl) expression in the presumptive notochord and
roadening of shh expression along the floor plate in
kk1-overexpressing embryos (data not shown). We
hus conclude that zebrafish ikk1 inhibits NF-κB activity
oth in vitro and in vivo.
In mammals, the activity of IKK1 and IKK2 is depen-
ent on their association with the noncatalytic subunits
EMO and ELKS [7, 8, 20]. To investigate whether, in
ebrafish, the presence of noncatalytic subunits is also
ssential for Ikk1 activity, we cloned the zebrafish nemo
omolog (GenBank AY735398). Zebrafish nemo en-
odes a 602 aa polypeptide (w70 kDa), which is longer
han the mammalian NEMO but still 47% identical (see
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1293Figure 2. ikk1 Knockdown Induces NF-κB-
Mediated Apoptosis
(A) Real-time PCR with total RNA from wild-
type (noninjected) ikk1 morphants (ikk1-MO)
or control morphants (ikk1m4-MO). The fold
induction of normalized gene expression is
indicated on the Y-axis. The values pre-
sented are averages of three replicates (plus
standard deviation) performed in at least two
independent experiments.
(B) TUNEL assay in developing embryos (30
hpf). An increased amount of apoptotic cells
is indicated on the tail region of ikk1 mor-
phants (blue arrows).
(C) Treatment of ikk1 morphants with NF-κB-
activation inhibitor (NAI, red bar) or DMSO
(control) to check rescue of the ikk1-MO
phenotype. The truncation and increased
apoptosis (TUNEL) along the tail of ikk1 mor-
phants were efficiently rescued after NAI
treatment (arrows). MO distribution was vis-
ualized by fluorescent microscopy with fluo-
rescein-labeled morpholinos.compared to the IP Nemo (Figure S1B), suggesting theing EGFP, ikk1, or nemo and GST-IκBα (1-54) as a sub-
Figure 3. ikk1 Expression Negatively Regu-
lates NF-κB
(A) Real-time PCR for IL-6 and IkBa, with to-
tal RNA from IKK1−/− MEFs expressing GFP,
mIKK1, or ikk1 under basal or TNFα stimula-
tion (10 ng/ml for 60 min). The values pre-
sented are averages of three replicates (plus
standard deviation) performed in at least two
independent experiments.
(B) Mobility-shift assay (EMSA) with total ly-
sates of 293T cells transfected with 15 g (+)
or 30 g (++) of ikk1 or mIKK1 vectors, under
basal (−) or TNFα stimulation. Western blot
was performed to check transgene ex-
pression.
(C) Luciferase measurement from ZF4 cells
expressing GFP, mIKK1, or ikk1, under basal
or LPS stimulation. Luciferase values were
normalized with β-galactosidase activity and
indicated on the Y-axis. The values are pre-
sented as described in (A).
(D) Overexpression of ikk1 in zebrafish em-
bryos (96 hpf). Embryos present partial or
complete lack of tail formation, eventual cy-
clopia, and irregularities along the A/P axis.
A GFP-injected embryo is shown as control
(top).Figure S1A in the Supplemental Data available with this
article online). Kinase assays were then performed with
transduced zebrafish cells (ZF4) constitutively express-strate (containing the inducible phosphorylation sites,
Ser-32 and Ser-36). Immunoprecipitated (IP) Ikk1 had a
marginal LPS-mediated phosphorylation of IκBα when
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1294Figure 4. Ikk1 Represses NF-κB Activation by Sequestering NEMO
(A) Immunoblotting with immunoprecipitated (IP) complexes isolated from 293T cells expressing GFP, FLAG-ikk1, or FLAG-ikk1DNBD, with
mNEMO-Myc or nemo-Myc. The NEMO bands are indicated (arrowheads).
(B) Luciferase measurement from ZF4 cells expressing GFP, ikk1, or ikk1DNBD, under basal or LPS stimulation. The values presented are
averages of three replicates (plus standard deviation) performed in at least two independent experiments.
(C) Real-time PCR for IkBa, with total RNA from IKK1−/− MEFs expressing GFP, ikk1, or ikk1DNBD, under basal or TNFα stimulation. The
values are presented as described in (B).
(D) Immunoblotting from total lysates of transduced IKK1−/− MEFs (as shown in [C]), with respective antibodies. The duration of TNFα
treatment was standardized to allow efficient analysis of IκBα phosphorylation but not its proteasome-dependent degradation.
(E) Illustrative graphic showing the percentage of embryos (28 hpf) with midline defects after injection of respective cRNAs. The picture of
the typical phenotype, with the amount of injected embryos (n) under each condition, is presented.presence of another kinase (or kinases), such as a puta- t
rtive IKK2 ortholog, may be essential for stimulus-
dependent NF-κB activation in zebrafish cells. Similar b
Iresults were observed in transduced IKK1−/− MEFs after
TNFα treatment Figure S2. Ikk1 does not bind IKK2 and t
pweakly binds IκBα in transduced IKK1−/− MEFs (Figure
S2). l
pAlthough Ikk1 has little or no IκB kinase activity, it is
capable of binding NEMO proteins (Figure 4A, lanes 2 d
sand 5). We hypothesized that Ikk1 might be a compo-
nent of a distinct IKK signalsome involved in negatively a
aregulating the NF-κB pathway by sequestering NEMO
from association and activation of another authentic t
zIKK complex. Hence, if we prevent Ikk1 association
with NEMO, its negative activity will be compromised. j
rTo test this, we truncated the Ikk1-specific NEMO bind-
ing domain (NBD), a C-terminal hexapeptide region
i(L/QDWSWT/L) highly conserved among the catalytic
IKK subunits [21]. As expected, truncation of NBD from b
tIkk1 (ikk1NBD) abolishes its interaction with NEMO
homologs (Figure 4A, lanes 3 and 6). Luciferase assays t
oin ZF4 cells expressing EGFP, ikk1, or ikk1DNBD reiter-
ated that Ikk1 represses stimulus-dependent NF-κB ac- c
ftivation, but the depletion of NBD negates its ability to
repress NF-κB activity (Figure 4B). Furthermore, we iso- T
clated total RNA from transduced IKK1−/− MEFs ex-
pressing EGFP, ikk1, or ikk1DNBD and performed real- a
ttime PCR for expression of IκBα, a prototype NF-κBarget gene. Again, we found that the ability of ikk1 to
epress expression of NF-κB target genes is abolished
y removal of NBD (Figure 4C), supporting the idea that
kk1-mediated NF-κB repression depends on the in-
eraction with NEMO proteins. In IKK1−/− MEFs, IκBα is
hosphorylated upon TNFα stimulation (Figure 4D,
anes 1 and 2). The addition of Ikk1 decreases IκBα
hosphorylation (Figure 4D, lanes 3 and 4), but, after
epleting NBD, the IKK phosphorylation activity is re-
tored (Figure 4D, lanes 5 and 6). The inhibition of IKK
ctivity is possibly due to the competition of Ikk1 with
nother catalytic subunit (or subunits) by Nemo pro-
eins. Indeed, in mammalian cells, immunodepletion of
ebrafish Ikk1 takes away NEMO but not IKK2, the ma-
or IκB kinase (Figure S3). In contrast, depletion of mIKK1
esults in loss of both IKK2 and NEMO (Figure S3).
On the basis of the data shown here, it appears that
kk1 expression promotes inhibition of NF-κB activation
y sequestering Nemo from functional IKK complexes
o form alternate signalsomes. To pursue the notion
hat Nemo sequestration may be the reason for ikk1-
verexpressing phenotype, we injected ikk1NBD
RNA in zebrafish embryos, and this injection caused
ew or no defects in the midline structure (Figure 4E).
hen, we coinjected ikk1 and nemo cRNAs into one-
ell-stage embryos and examined whether increased
vailability of Nemo would rescue the mutated pheno-
ype. Interestingly, the coinjections promoted 50%–
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129560% rescue of the ikk1-overexpressing phenotype (Fig-
ure 4E). This result strongly indicates that the availabil-
ity of Nemo proteins overcomes the ikk1-overexpress-
ing phenotype, presumably by reconstituting functional
IKK complexes, which restore the basal NF-κB activity.
In fact, nemo knockdown can rescue the “strong” phe-
notype of ikk1 morphants (data not shown) because of
the normalization of Nemo levels to wild-type condi-
tions. These results demonstrate that the mechanism of
NF-κB repression by Ikk1 involves the interaction and
sequestration of NEMO homologs from functional IKK
complexes.
Our present study suggests that IKK1 has an evolu-
tionarily contrasting role in NF-κB activation, possibly
operating as a “fail-safe system” to avoid constitutive
activation of NF-κB proteins, which could influence
generalized developmental arrest and embryonic mal-
formations. Given that constitutive induction of NF-κB-
responsive genes could be toxic, rapid shutoff of NF-
κB activity is essential for cell survival. Recently, it has
been reported that mammalian IKK1 can also suppress
NF-κB in macrophages, albeit by a distinct mechanism
[22]. Putting our data together with this recent finding,
we conclude that IKK1 has evolved to negatively regu-
late NF-κB activity in certain model systems. The iden-
tification of an alternative IKK1-NEMO complex might
help us better understand the canonical pathway of NF-
κB activation and its role in embryogenesis. In addition,
deciphering the upstream signals that modulate dif-
ferential IKK signalsomes will certainly provide new in-
sights on the understanding of vertebrate development.
Supplemental Data
Supplemental Data include three figures and Supplemental Experi-
mental Procedures and are available with this article online at:
http://www.current-biology.com/cgi/content/full/15/14/1291/DC1/.
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